Erasca, Inc.
ERASNASDAQHealthcare● Active
$12.91
+$0.94(+7.85%)
Market Cap$4.0B
P/E Ratio—
52W High$24.28
52W Low$1.21
Erasca, Inc.（ERAS）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ERAS · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.09B | $0.12B | $0.10B | $0.11B | $0.07B |
| G&A Expenses | $0.04B | $0.04B | $0.04B | $0.03B | $0.02B |
| Total Operating Expenses | $0.13B | $0.18B | $0.14B | $0.24B | $0.12B |
| Operating Income | ($0.13B) | ($0.18B) | ($0.14B) | ($0.25B) | ($0.12B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.02B | $0.02B | $0.02B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.20B | $0.00B |
| Income Before Tax | ($0.12B) | ($0.16B) | ($0.13B) | ($0.24B) | ($0.12B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.12B) | ($0.16B) | ($0.13B) | ($0.24B) | ($0.12B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.03 |
| Wtd Avg Shares | 0.28B | 0.23B | 0.15B | 0.12B | 0.12B |
| EBITDA | ($0.13B) | ($0.15B) | ($0.12B) | ($0.24B) | ($0.12B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Erasca, Inc.
关于Erasca, Inc.（ERAS）损益表
Erasca, Inc.（ERAS）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，ERAS实现营收$0.00B，毛利润($0.00B)（毛利率—），净利润($0.12B)（净利率—）。
常见问题
ERAS · 4 问Erasca, Inc.（ERAS）2025财年营收为$0.00B，同比down—%。
ERAS revenueERAS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08